5-fluorouracil,oxaliplatin,Irinotecan
Not Tagged
['pancsm', 'pancreatic']
disappointed with norpact-1 results. once again reinforcing that response does not always translate to clinical benefit. is time to stop chasing new targets for pancreatic cancer and start working on improving the efficacy of old drugs? #asco23 #pancreaticcancer #pancsm
Assistant Professor - Clinical at @OSUCCC_James.                                            GI Medical Oncologist